跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 388 条关于
“NF-KB”
全部
388
临床试验
104
药物
156
机构
3
资讯
125
7个月前
Primmune Therapeutics Raises $8.6M to Advance TLR7 Agonist PRTX007 into Phase 2 Melanoma Trial
2个月前
Curis Opens Eleven Clinical Sites for Phase 2 TakeAim CLL Study of Emavusertib–Zanubrutinib Combination
去年
Tivic Health Advances Entolimod Development with Two FDA Investigational New Drug Applications
2年前
BioVie's Bezisterim Receives Final Approval for Phase 2 Long COVID Trial
10个月前
Tivic Health Secures BARDA Meeting to Advance Entolimod for Acute Radiation Syndrome
去年
Elraglusib Granted FDA Rare Pediatric Disease Designation for Ewing Sarcoma
去年
Arrivo BioVentures Repurposes Depression Drug SP-624 Targeting Gender-Specific Gene Expression
去年
Elraglusib Receives EMA Orphan Drug Designation for Pancreatic Cancer Treatment
去年
Elraglusib Shows Promise for Advanced Salivary Gland Carcinoma in Upcoming AACR Presentation
去年
NFKB1 Haplotype Predicts Improved Response to Ropeginterferon Alfa-2b in PV and ET
第 1 页,共 13 页
上一页
下一页